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Levy DI, Wanderling S, Biemesderfer D, Goldstein SA. MiRP3
acts as an accessory subunit with the BK potassium channel. Am
J Physiol Renal Physiol 295: F380–F387, 2008. First published May
7, 2008; doi:10.1152/ajprenal.00598.2007.—MinK-related peptides
(MiRPs) are single-span membrane proteins that assemble with
specific voltage-gated K (Kv) channel -subunits to establish
gating kinetics, unitary conductance, expression level, and phar-
macology of the mixed complex. MiRP3 (encoded by the KCNE4
gene) has been shown to alter the behavior of some Kv -subunits
in vitro but its natural partners and physiologic functions are
unknown. Seeking in vivo partners for MiRP3, immunohistochem-
istry was used to localize its expression to a unique subcellular site,
the apical membrane of renal intercalated cells, where one potas-
sium channel type has been recorded, the calcium- and voltage-
gated channel BK. Overlapping staining of these two proteins was
found in rabbit intercalated cells, and MiRP3 and BK subunits
expressed in tissue culture cells were found to form detergent-
stable complexes. Electrophysiologic and biochemical evaluation
showed MiRP3 to act on BK to reduce current density in two
fashions: shifting the current-voltage relationship to more depolar-
ized voltages in a calcium-dependent fashion (10 mV at normal
intracellular calcium levels) and accelerating degradation of
MiRP3-BK complexes. The findings suggest a role for MiRP3
modulation of BK-dependent urinary potassium excretion.
KCNE4; KCNMA1; MaxiK; slo; intercalated cells
MINK AND THE MINK-RELATED peptides (MiRPs) are proteins with
a single transmembrane span that associate with potassium
channels to modulate their function (3, 4). The importance of
these proteins to normal physiology of the heart and nervous
system is exposed by their association with clinical disorders
such as congenital long QT syndrome, drug-induced cardiac
arrhythmias, sensorineural deafness, and periodic paralysis (1,
4, 48, 49, 51). In addition, MiRPs influence the normal
physiology of endocrine and exocrine glands, intestinal
secretion, and renal excretion (32). Because the peptides are
promiscuous in their roles and interact with a wide variety
of potassium channels (2), careful evaluation is required to
delineate bona fide (in vivo) relationships. Thus, the capac-
ity of a specific MiRP to alter function of a channel complex
in vitro does not necessarily correlate with their interaction
in vivo (33).
MinK-related peptide 3 (MiRP3), encoded by the KCNE4
gene, enjoys broad mRNA expression in mice and humans (20,
31) and a role in human heart has been suggested (7, 19, 29,
46). Here, we undertook an approach to identifying physiolog-
ical partners for MiRP3 similar to that used previously for
MiRP1 and MiRP2 (1, 4). Polyclonal antibodies were raised
and used to localize MiRP3 to a particular cell type and locale
in vivo. Thereafter, potassium channels known to operate at the
site were evaluated. Thus, MiRP3 was localized to the special-
ized apical membrane of renal intercalated (IC) cells where the
only potassium channel characterized to date is the voltage-
and calcium-gated BK channel (39, 40, 62). Functional part-
nership of MiRP3 and BK was therefore evaluated. Studies in
cultured cells revealed mono-glycosylation and type I mem-
brane orientation of MiRP3, stable complex formation of
MiRP3 and BK, and MiRP3 reduction of BK currents due to a
shift in the current-voltage relationship to more depolarized
voltages, 10 mV at 0.1 M intracellular calcium ([Ca2]i),
and enhanced channel degradation. The effect of MiRP3 on
activation is similar to that seen with KCNMB-encoded BK
accessory subunits (proteins with 2 transmembrane spans), and
the control of channel half-life may be similar to a form of
channel regulation by KCNMB1 that was recently described
(54). A role for MiRP3 in urinary potassium excretion is
considered.
EXPERIMENTAL PROCEDURES
Molecular biology. The coding regions of human, rat, and rabbit
KCNE4 genes (NCBI NM_080671, AF512994, and AY926882, re-
spectively) were cloned from cDNA libraries and subcloned with a
Kozak consensus sequence (GCCACC) before initiating the methio-
nine codon into a vector (pRAT) that is optimized for both oocyte and
mammalian expression (10). Plasmids containing human KCNMA1
and KCNMB1 (NCBI U11058 and NM_004137, respectively) were
gifts from Dr. L. Toro and these genes were cloned into pRAT as
described for KCNE4. An epitope-tagged variant of BK was
engineered by introducing a linker (RVPDGDPD) followed by the
bacterial rhodopsin sequence, 1d4 (ETSQVAPA), at the COOH
terminus.
Antibody development. Three epitopes of the MiRP3 cytoplasmic
tail were chosen for generation of polyclonal antibodies, consisting of
amino acid residues 67-138, 136-150, and 151-170. These epitopes
are largely conserved across human, rat, and rabbit homologs. A GST
fusion protein was produced that contained residues 67-138, after
subcloning the encoding nucleotide sequence in frame into the mul-
tiple cloning site of pGEX 6p-1. The two other epitopes were
generated by conjugating synthetic peptides to keyhole limpet hemo-
cyanin (Calbiochem, San Diego, CA) (21). The immunogens were
used for inoculation of rabbits by Pocono Rabbit Farms & Laborato-
ries (Canadensis, PA). The serum immunoglobulins were purified
with protein A sepharose beads (Amersham Biosciences, Piscataway,
NJ), and affinity purification of the anti-MiRP3 antibodies was made
with immobilized antigens.
Address for reprint requests and other correspondence: S. A. N. Goldstein or
D. I. Levy, Univ. of Chicago, Section of Nephrology, MC5100, 5841 S.
Maryland Ave., Chicago, IL 60637-1447 (e-mail: sangoldstein@uchicago.edu
or dlevy@medicine.bsd.uchicago.edu).
The costs of publication of this article were defrayed in part by the payment
of page charges. The article must therefore be hereby marked “advertisement”
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Am J Physiol Renal Physiol 295: F380–F387, 2008.
First published May 7, 2008; doi:10.1152/ajprenal.00598.2007.
0363-6127/08 $8.00 Copyright © 2008 the American Physiological Society http://www.ajprenal.orgF380
Immunohistochemistry. All animal experimentation was conducted
in accordance with the Guide for the Care and Use of Laboratory
Animals (National Institutes of Health, Bethesda, MD) and was
approved by the local Institutional Animal Care and Use Committees.
Rats were fed normal or high potassium diets (1 and 5% wt/wt,
respectively) and rabbits were fed a high potassium (5% wt/wt) diet
for 7–10 days before death. Their kidneys were fixed in 2.5%
paraformaldehyde, cryopreserved with 15% sucrose, and embedded in
Cryo-Gel (Instrumedics, St. Louis, MO) before being sectioned at 5
m. Epitope retrieval was performed with 10 mM sodium citrate, pH
6.0, and sections were subsequently permeabilized with 0.25% Triton
X-100 and 0.1% Tween-20 in phosphate-buffered saline and blocked
with 10% donkey serum. Rat sections were incubated for 1 h at room
temperature with mouse anti-anion exchanger 1 (AE1) at 1:100
(IVF12; University of Iowa Developmental Hybridoma Bank) and
either rabbit anti-MiRP3136-150 at 1:500 or rabbit anti-MiRP3151-170 at
1:250. This was followed by Alexa Fluor 488 donkey anti-mouse
1:600 and Alexa Fluor 594 donkey anti-rabbit 1:600 (Invitrogen,
Carlsbad, CA) secondary antibodies. Rabbit sections were incubated
with primary antibodies overnight at 4°C: chicken anti-BK (37) at
1:200 (a gift from Dr. T. Kleyman), rabbit anti-aquaporin-2 (63) at
1:30,000 (a gift from M. Cadnapaphornchai), and goat anti-MiRP3 at
1:100 (KCNE4 N-14; Santa Cruz Biotechnology, Santa Cruz, CA)
followed by respective secondary antibodies for 1 h at room temper-
ature: Texas Red donkey anti-chicken 1:300 (Jackson Immunore-
search, West Grove, PA), Alexa Fluor 488 donkey anti-rabbit 1:600,
and Alexa Fluor 647 donkey anti-goat 1:300 (Invitrogen). All samples
were mounted with Vectashield hard set mounting medium (Vector
Laboratories, Burlingame, CA) and imaged with a 63 objective.
Biochemistry. Rat hearts and kidneys were obtained frozen from
Pel-Freez (Rogers, AR). Tissue was homogenized in lysis buffer (in
mM): 100 NaCl, 40 KCl, 20 K-HEPES, 1 Na-EDTA, 10% vol/vol
glycerol, and protease inhibitor tablets (Roche Applied Science,
Indianapolis, IN), pH 7.4, and then solubilized by adding 2% Triton
X-100 (Roche Applied Science). After centrifugation to remove
insoluble materials, lysates were fractionated by SDS-PAGE.
Transformed African green monkey kidney fibroblast cells (COS-7)
and Chinese hamster ovary K-1 (CHO) cells were cultured in DMEM
and -MEM (Invitrogen), respectively, supplemented with 10%
FBS and held at 37°C in humidified air with 5% CO2. Cells were
transfected for biochemistry with 10–20 g of plasmid DNA in
150-mm dishes by adding 2 l Lipofectamine 2000 (Invitrogen) per 1
g DNA in 3 ml of Opti-MEM added to 15 ml of medium. The cells
were rinsed with fresh culture medium after 2 h and harvested
12–36 h later. Pellets of harvested cells were solubilized for 1 h in
lysis buffer containing 1% Triton X-100, and insoluble material was
removed by centrifugation. Immunopurification of epitope-tagged BK
was performed as before by Kim et al. (25) with anti-1d4 monoclonal
antibody (National Cell Culture Center, Minneapolis, MN) linked to
sepharose beads and elution with 1 mg/ml 1d4 peptide.
Steady-state biotinylation experiments used CHO cells transfected
with vector for wild-type BK channels along with an equal concen-
tration of vector that was empty or carried KCNE4. Twenty-four hours
after transfection, cells were incubated with 1.5 mM sulfo-NHS-SS-
biotin (Pierce, Rockford, IL) in PBS (pH 8.0) for 30 min at room
temperature. Cells were rinsed and solubilized and samples were
diluted to normalize total protein concentration. Biotin-labeled pro-
teins were isolated by incubation with streptavidin beads (Pierce) for
1 h at 4°C and liberated by incubation with 4 SDS-PAGE sample
buffer with 200 mM dithiothreitol for 15 min at 55°C.
Pulse-chase experiments were carried out by transfecting CHO
cells with vector for the 1d4-tagged variant of BK along with an equal
concentration of second vector that was empty or carried KCNE4 or
the similarly sized Iip35 coding sequence. Because the length of the
empty vector is 10% shorter than the KCNE4 or Iip35 vectors, there
was a 10% greater number of copies of the second vector in the
control group. Twelve hours after transfection, cells were starved for
1 h in pulse media: thiol-free DMEM (Invitrogen) supplemented with
1 mM pyruvate, 2 mM glutamine, and 10% dialyzed FBS; this was
followed by a 1-h incubation in pulse media containing 150 Ci/ml
of 35S-labeled methionine and cysteine (Pro-mix, Amersham Bio-
sciences). After the pulse, cells were rinsed with -MEM supple-
mented with 2 mM cold methionine and cysteine. The cells for the 1-h
time point were biotinylated as above and the remaining dishes of cells
were chased under normal culture conditions until biotinylation. After
biotinylation, cells were harvested, pelleted, and frozen at80°C until all
groups of cells were simultaneously lysed for BK-1d4 purification with
sepharose beads covalently linked to 1d4 antibody. A small sample of
lysates was saved for estimation of total incorporated radioactive label by
trichloroacetic acid (TCA) precipitation and used to assess 35S incorpo-
ration and cell recovery. After 1d4 peptide elution, 15% of the purified
BK was saved for electrophoresis and the remainder was used for
purification of the surface component. The samples were analyzed by
SDS-PAGE and autoradiography (Storm 860, Amersham Biosciences),
and values for radiolabeled BK were scaled to TCA precipitable counts
using an interpolated line of decay to control for recovery of sample.
Half-life was determined by fitting BK expression from 6 to 16 h with the
function y  yo 2x/T, where T is the half-life of BK counts (h) and yo
represents the y-intercept.
Western blotting. Western blots were probed with anti-MiRP3136-150
and a mouse monoclonal antibody to the BK690-891 epitope (35)
purchased from the UC Davis/NINDS/NIMH NeuroMab Facility
(Davis, CA). Blots were imaged on a Licor Odyssey (Lincoln, NE)
using fluorescent secondary antibodies, and bands were quantified via
Odyssey software.
Patch-clamp experiments. CHO cells were prepared for electro-
physiology by transfecting and then plating onto glass coverslips in
35-mm culture dishes. The transfections were performed with an
additional vector encoding a variant of green fluorescent protein,
pEGFP (Clontech, Palo Alto, CA). Transfected cells were identified as
those with green fluorescence during brief illumination with a mer-
cury lamp, and typically represented 20% of the total population of
cells. All recordings were made in the inside-out mode using an
Axopatch 200A amplifier (Axon Instruments) and CLAMPEX soft-
ware. Macroscopic recordings of 0.4–6.0 nA were made with boro-
silicate electrodes of 1- to 4-M resistance, and single-channel
recordings were made with 8-M electrodes. Data acquisition
began10 min after pulling off the patch, once it was established that
the conductance-voltage (G-V) relationship was stable in the experi-
mental solution.
Pipette solution contained (in mM) 105 KOH, 10 HEPES, 5 KCl, 2
N-(2-hydroxyethyl)ethylenediamine-N,N	,N	-triacetic acid (HEDTA), 10
M free Ca2, pH 7.20, with methanesulfonic acid. The bath solution
was identical except that CaCl2 was added to achieve a range of free
Ca2 between 0.1 and 50 M, as calculated by MaxChelator software
(41), and titrated with a calcium electrode (Thermo-Orion, Beverly,
MA). All solutions were held in plastic containers to prevent leeching
of calcium from glass bottles.
RESULTS
MiRP3 is expressed on the apical membrane of renal IC
cells and colocalizes with the BK channel. Rabbit polyclonal
antibodies were generated against three distinct amino acid
sequences in the cytoplasmic tail of MiRP3 that share at least
90% identity in human, mouse, and rat isoforms. Antibodies
were affinity-purified on peptide antigen and proved useful for
Western blotting and immunohistochemistry. Based on reports
of KCNE4 mRNA expression in kidney (19, 20, 53), ultrathin
sections of rat kidney were stained (8, 9), localizing MiRP3
protein to the apical (luminal) membranes of IC cells of renal
cortex and medulla (Fig. 1A). The stained cells were identified
as type A IC cells by their morphology, number, and counter-
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staining of the basolateral membrane with a monoclonal antibody
to the chloride-bicarbonate exchanger, AE1 (Fig. 1, B and C) (5,
52). Because virtually all cells staining for AE1 also stained for
MiRP3, it is likely that MiRP3 is present in both connecting
tubule (CNT) and collecting ducts (24). Staining was judged to
be specific, as a similar signal was found for antibodies to two
MiRP3 epitopes and signal was eliminated when MiRP3 anti-
bodies were preincubated with antigen (not shown). Focal
expression of MiRP3 on IC apical membranes suggested it
might interact with BK potassium channels which had previ-
ously been localized to this specialized membrane by electro-
physiology (39, 40) and immunohistochemistry (62). Colocal-
ization of MiRP3 and BK channels was attempted in rat
kidney, but anti-BK antibodies were not effective for staining
rat kidney, even when tissue was taken from rats on a high
potassium diet.
MiRP3 and BK were subsequently colocalized in IC cells of
rabbit kidney. Using goat anti-MiRP3, chicken anti-BK, and
rabbit anti-AQP2 antibodies, strong MiRP3 expression on the
apical surface of IC cells was confirmed in rabbit cortex and
medulla and found to costain with BK (Fig. 1, D–H). In rabbit
kidney, however, there was also weak staining of BK and
MiRP3 in some principal cells (arrowheads, Fig. 1, D and E).
This expression pattern has been noted for BK in rabbit kidney
(37, 62). Staining was lost when either MiRP3 or BK antibod-
ies were preincubated with blocking peptide (Fig. 1I, for
MiRP3 antibodies). MiRP3 antibody also identified IC cells
when no BK antibody was used and BK was similarly identi-
fied when no MiRP3 antibody was used (not shown). Although
BK is known to be expressed in vascular smooth muscle, we
did not detect BK staining of renal vessels.
MiRP3 is a glycosylated type I protein. MiRP3 protein in rat
tissue lysates and heterologously expressed in CHO cells was
evaluated by Western blot analysis. Two specific bands were
visualized at 22–28 kDa from heart, kidney, and cells transfected
with human MiRP3 but not with vector-transfected cells, using
antibodies to MiRP3136-150 or MiRP3151-170 epitopes (Fig. 2A),
consistent with findings of Manderfield and George (31); bands
were specifically eliminated by preincubation of antibodies with
immunizing antigen (not shown). Native MiRP3 showed a larger
apparent mass than heterologously expressed protein suggesting
differences in posttranslational modification.
Treatment of heterologously expressed MiRP3 with the
deglycosidase PNGase F led to an 2-kDa decrease in the
apparent mass, as did mutation of the asparagine at MiRP3
position 8 to glutamine (MiRP3 N8Q) removing the single
canonical consensus sequence for N-linked glycosylation (Fig.
2B). Migration of MiRP3 N8Q was not modified by PNGase F
treatment. These findings suggest that native MiRP3 is glyco-
sylated in native tissues and is a type I membrane protein (that
is, bearing an external NH2 terminus) like other members of
KCNE family (1, 4, 13).
MiRP3 and BK stably interact within cells. Because MiRP3
and BK are expressed on the same cell membrane, MiRP3 was
overexpressed in CHO cells with a variant of human BK
modified to carry the 1d4 epitope on its COOH terminus
Fig. 1. MiRP3 expression in the kidney colocalizes with BK channel to the apical membrane of intercalated (IC) cells. Staining of rat kidney cortex (top) shows
localized expression of MiRP3 (anti-MiRP3136-150; A) on the apical membrane of IC cells and expression of the chloride-bicarbonate exchanger AE1 (B) on the
basolateral membrane of the same cells (merge; C). This staining pattern was also found with the anti-MiRP3151-170 antibody (not shown). Coexpression of
MiRP3 and BK channel is shown in rabbit renal cortex (middle and bottom) with goat anti-MiRP3 (D), chicken anti-BK (E), rabbit anti-aquaporin 2 (F; merged
image, G), using the anti-aquaporin antibody as a marker for the adjacent principal cells. A DIC image (H) of the tubule shown in D–G is presented to aid in
cell identification. Peptide against MiRP3 (I) was used to show specificity of the antibody. Scale bars indicate a distance of 25 m, and arrowheads point to
principal cells that stain weakly for MiRP3 and BK.
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(BK-1d4). Proteins were purified after detergent lysis of the
cells via monoclonal antibodies specific to the tag. Figure
2C shows that MiRP3 and BK-1d4 are purified together,
indicating that they form detergent-stable complexes when
coexpressed. Recovery was specific since MiRP3 was not
recovered when the channel had no tag or when MiRP3 or
BK-1d4 was expressed alone. Coassembly of BK and MiRP3
within the cells rather than secondarily after solubilization was
demonstrated by the inability to copurify MiRP3 after mixing
lysates of cells expressing BK-1d4 with cells expressing
MiRP3. While total cell lysates reveal a third, smaller MiRP3
band, it appears to be a degradation product because only the
expected MiRP3 doublet is isolated via BK-1d4.
MiRP3 reduces macroscopic but not single-channel BK
currents. Net BK current was greatly reduced when MiRP3
was coexpressed. Representative traces for a family of depo-
larizing steps from 80 to 80 mV are shown in Fig. 3A, and
the mean conductance per membrane patch is presented in Fig.
3B. With bath [Ca2]i of 10 M, the mean (
SE) conductance
at 80 mV was 44.7 
 16.6 vs. 4.6 
 2.2 nS for patches from
cells transfected with BK without and with MiRP3, respec-
tively (n  9 for each group). Patches were equivalent in size
(electrode resistance 3.0 
 0.2 M for both groups) and
were taken from cells bearing similar, moderate fluores-
cence. As expected, expression of MiRP3 alone yielded no
currents since the accessory subunit does not form a channel
on its own (Fig. 3A).
Possible explanations for reduced BK current include a smaller
unitary conductance, a change in the voltage required to activate
the channels, and/or decreased expression of BK at the plasma
membrane. To assess the mechanism for current reduction, single-
channel recordings were performed. Figure 3C shows represen-
tative recordings of BK (left) and BK expressed with MiRP3
(right) over a range of membrane potentials with 1 M [Ca2]i.
Comparing slope conductances of 5 patches in each group (Fig.
3D) revealed no change in BK unitary current with MiRP3
(means
 SE conductances were 280
 8 and 289
 5 pS, for BK
without and with MiRP3, respectively).
MiRP3 shifts BK activation to depolarized potentials in a
calcium-dependent manner. To determine the voltage required
to activate BK channels half-maximally (V1⁄2-act), various volt-
ages and calcium concentrations were studied. At 10 M
[Ca2]i, MiRP3 coexpression causes a 22-mV shift of V1⁄2-act,
from 17.8 
 7.7 to 4.0 
 3.9 mV (Fig. 3E). In 0.1 M
[Ca2]i, approximating steady-state intracellular concentration
in IC cells (61), the shift in V1⁄2-act was 9 mV, from 62.2 

4.1 to 71.1 
 3.0 mV (means 
 SE, n  6 patches each).
Half-maximal activation voltages plotted as a function of
[Ca2]i show that the MiRP3-induced shifts wane slightly as
calcium levels are reduced (Fig. 3F).
MiRP3 accelerates degradation of cellular BK. The magni-
tude of MiRP3-induced shift in V1⁄2-act is insufficient to fully
explain the reduction of BK current. This suggested MiRP3
might also regulate turnover of BK channels which was con-
firmed as follows: BK surface expression was quantified by
labeling cell surface proteins exposed to the extracellular
solution with a membrane-impermeant biotin reagent that re-
acts with primary amines and purification the labeled proteins
via streptavidin immobilized on beads. Total and surface BK
expression in transfected CHO cells were quantified without
MiRP3 (vector control) and with MiRP3 (Fig. 4A). At
steady state, MiRP3 reduced the total BK expression by
60 
 1% and reduced surface BK protein by 75 
 8%
(means 
 SD, n  3).
The reduction of total and surface BK suggested MiRP3-BK
complexes might have a shortened half-life. Indeed, proteolysis
of the entire pool of cellular BK was accelerated by MiRP3
coexpression. The kinetics of BK expression were studied by
metabolically labeling proteins with 35S-methionine and
35S-cysteine for 1 h and quantifying the expression of the total
cellular and surface-expressed BK over the next 16 h. To
exclude the possibility that BK expression might be atten-
uated nonspecifically by simple competition with MiRP3 for
the protein synthetic machinery, a control was included in
which BK was coexpressed with a noninteracting single-
transmembrane protein, the major histocompatability anti-
gen class II-associated invariant chain, Iip35. Figure 4B
shows raw data from one of the three experiments used to
quantify the time course for recovery of BK when coex-
pressed alone, with MiRP3, or with Iip35. Figure 4C shows
the kinetics of BK for the experiment shown in 4B, reveal-
ing a close correlation between the decay of total channel
and the surface-expressed channel in all three experimental
Fig. 2. MiRP3 expression and its copurification with BK. A: bands of
22–28 kDa are seen for homogenates of rat heart, rat kidney, and Chinese
hamster ovary (CHO) cells transfected with human MiRP3 (hMiRP3).
Lysates from CHO cells transfected with empty vector (NT) did not stain
for MiRP3. B: lysates of COS-7 cells expressing wild-type hMiRP3,
incubated for 45 min with PNGase, show a size decrease of 2 kDa. The
migration of hMiRP3-N8Q is equivalent to that of PNGase-treated wild-
type protein and unchanged by PNGase treatment. C: CHO cells with
hMiRP3 (a), hMiRP3 and BK (b), hMiRP3 and BK-1d4 (c), or BK-1d4
alone (d) were subjected to lysis and immunopurification with anti-1d4
antibodies. An additional treatment group (e) consisted of lysate from cells
expressing MiRP3 mixed with lysate from cells expressing BK-1d4, incu-
bated together at 4°C for 16 h before immunopurification (IP). MiRP3 is
purified only when coexpressed with BK-1d4.
F383MiRP3 PARTNERS WITH BK
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groups. Coexpression with MiRP3 decreased BK half-life
(total and surface) 60% compared with BK alone or BK
with Iip35 (Fig. 4D, n  3). For all three groups, there was
an 4-h delay between the pulse and peak surface expres-
sion, as noted by Bravo-Zehnder et al. (11) in their charac-
terization of sorting of BK to apical membrane in Madin-Darby
canine kidney cells.
DISCUSSION
The physiological roles of MiRP3 are unknown. Here,
MiRP3 was localized to the apical membrane of renal IC cells
and found to be coexpressed with the voltage- and calcium-
activated BK channel. This prompted an evaluation that dem-
onstrated stable interaction of MiRP3 and BK in cultured cells
and two mechanisms by which MiRP3 reduces BK current:
requirement for greater depolarization to open the channels
(10 mV at natural calcium concentration in IC cells), and
lowered expression at the plasma membrane due to decreased
BK half-life. MiRP3 is similar to other KCNE family proteins
in altering both activation voltage and expression levels of
complexes formed with classical voltage-gated potassium
channels (3, 32) but is the first member found to interact with
voltage- and calcium-gated BK channels.
The KCNMB accessory subunits are well-characterized
modulators of BK channels that shift activation voltage either
to more hyperpolarized (KCNMB1) or depolarized potentials
(KCNMB4) at physiologic calcium concentrations (12, 16). As
found for MiRP3, these effects wane with reduced intracel-
lular calcium. Calcium-dependent effects of MiRP3 may be
due to a direct influence on calcium binding or, as proposed
for KCNMB1, the result of altered impact of calcium on
activation gates and/or the effective gating charge of the
voltage sensor (6, 16, 38, 44).
MiRP3 can also modify BK channel protein expression level,
and this type of effect is not unprecedented for the KCNE family.
MinK (encoded by KCNE1) can increase hERG channel expres-
sion by promoting the trafficking of channels to the cell surface
(34), although enhanced degradation has not been described
previously for the KCNE proteins. How might MiRP3 speed
turnover of BK? Recently, BK channel surface expression was
also shown to be specifically reduced by KCNMB1, as endocy-
tosis of BK was accelerated by the accessory protein. MiRP3
might act similarly, although Toro et al. (54) saw a minimal effect
on the total amount of BK channel. This difference may be due to
the relatively short time scale of their immunohistochemical
experiments (1 h), which may not have allowed appreciable
lysosomal degradation. Alternatively, MiRP3 may cause ubiquiti-
nization of BK, similar to the effect of the single transmembrane-
spanning protein, Vpu, which stably interacts with the potassium
leak channel, K2P3 (Task-1) (22).
BK channels are widely expressed and are modulated by a
variety of regulatory mechanisms depending on the cell type
and physiological conditions (28). During pregnancy, the myo-
metrium has increased mRNA and protein expression of a BK
splice variant that leads to retention of channel in the endo-
plasmic reticulum/golgi complex, decreasing levels at the
plasma membrane (64, 65). Similarly, endothelial-cell expres-
sion of caveolin-1 inhibits BK currents, perhaps by holding the
channels within lipid rafts (59). As discussed above, KCNMB1
may regulate BK surface expression in some cells. Shortening
the channel half-life by MiRP3 is yet another mechanism of
modulating the activity of BK.
Focal expression of MiRP3 on apical membranes of IC cells
underscores the fact that MinK-related peptides, like some of
their pore-forming partners, can be directed to specific subcel-
lular locations. Supporting native assembly of MiRP3 and BK
Fig. 3. Electrophysiologic effects of MiRP3 on BK currents.
Patch-clamp recordings from transfected CHO cells. A: repre-
sentative macroscopic recordings of inside-out patches from
cells transfected with BK and empty vector (BK), MiRP3 and
BK (hMiRP3  BK), or MiRP3 and empty vector (hMiRP3).
Voltage pulses were delivered for 400 ms at 0.4 Hz from a
holding potential of 60 mV. Perfusion solution contained 10
M free Ca2. B: mean (
SE) conductance at 80 mV is
compared for patches taken from cells expressing BK or BK 
MiRP3. C: representative single-channel recordings made from
cells transfected with reduced BK cDNA. The internal mem-
brane voltage for each recording is shown, and arrows indicate
the closed state of the channels. D: slope conductance (
SE) is
compared from single-channel recordings of BK vs. BK 
MiRP3. E: conductance-voltage relationship for BK without or
with MiRP3 at 3 different [Ca2]i. Conditions were as in A
except for varied [Ca2]i as indicated by the differently shaped
symbols. Filled symbols represent values (
SE) for BK alone
and open symbols for MiRP3 with BK. F: half-maximal acti-
vation (V1⁄2-act) over a range of internal calcium concentrations.
F384 MiRP3 PARTNERS WITH BK
AJP-Renal Physiol • VOL 295 • AUGUST 2008 • www.ajprenal.org
is observation of their coincident dense expression on apical
membranes of selected IC cells in rabbit kidney (Fig. 1). This
supposition is strengthened by a capacity for the subunits to
interact stably and to alter function in cultured cells (Figs.
2–4). Direct evidence for assembly of MiRP3 and BK in
mammalian kidney will require coimmunoprecipitation of the
proteins from native tissue, a challenging proposition with
members of the KCNE family. Finley and colleagues (17)
achieved coimmunoprecipitation of MinK with KCNQ1 and
ERG channels from horse heart and McCrossan et al. (33)
showed that MiRP2 forms stable complexes with either Kv2.1
or Kv3.1 in rat brain. Otherwise, numerous attempts at native
coprecipitation with KCNE proteins have had limited success
(32). An alternative, albeit indirect, approach to validate func-
tional association in vivo is targeted deletion of the KCNE4
gene (55, 56).
Whereas BK channels have a seventh transmembrane seg-
ment, S0 (57), they are otherwise like classical Kv voltage-
gated potassium channel subunits that have six membrane
spans and one pore-forming P loop and assemble as tetramers
to form a central ion conduction pathway (27, 30, 45, 50).
Therefore, the stoichiometry of MiRP3-BK complexes may be
hexameric-like IKs channels (15, 36, 58), that is, with two
MiRP3 and four BK subunits.
What role might MiRP3 play in the kidney? Flow-dependent
potassium secretion in the rabbit is mediated by apical BK
channels in IC cells (60, 62) and subject to modifications of
serum potassium concentration, such that a low potassium diet
in rabbits leads to a loss of BK channels from the apical surface
of IC cells and a marked reduction of flow-dependent K
secretion (37). Possible mechanisms for this effect include
downregulated expression of mRNA encoding the BK alpha
subunit (37), enhanced expression of KCNMB4 (18, 37),
channel suppression by mitogen-activated protein kinases (26),
as well as the above described effects of MiRP3. To explore
this possibility, an evaluation of the effects of dietary potas-
sium on MiRP3 expression in rabbit collecting duct is planned.
In mice, BK channels with the accessory subunit KCNMB1
are responsible for flow-dependent potassium secretion, and
activity appears to be confined to the CNT upstream of the
collecting duct (42, 43, 47). Because KCNMB1 is expressed
only in the principal-like cells of the CNT (18), it appears as if
flow-dependent kaliuresis in mice does not involve IC cells.
Less is known about the modulation of this phenomenon in rats
where flow-dependent kaliuresis is modulated by dietary po-
tassium (14, 23) but there is no apparent change of BK channel
activity of IC cells of the cortical collecting duct (40).
Flow-independent potassium transport involving active
H/K exchange in IC cells is also regulated by dietary
potassium content and might involve MiRP3 modulation. Zhou
and Wingo (66) demonstrated a pathway employing H-K-
ATPase-dependent potassium recycling that is required when
animals are fed a potassium-replete diet, presumably prevent-
ing acidosis-induced hyperkalemia. BK is likely to be the
channel mediating potassium efflux in this case and channel
downregulation is crucial when serum potassium levels drop.
These forms of regulating K flux in response to potassium
intake raise the intriguing possibility that under potassium-
deplete conditions MiRP3 could participate in the inhibition of
BK activity and minimize urinary potassium loss.
Fig. 4. MiRP3 shortens half-life of BK protein. A: CHO cells were transfected
with wild-type BK channels and an equal concentration of either empty vector
(BK) or MiRP3 (hMiRP3BK), allowing quantification of the total and
surface-expressed BK. The sample blot shows cotransfection of MiRP3 with
BK leading to a 61% reduction of total BK and an 84% reduction of surface
BK at steady state. B–D: pulse-chase experiments demonstrating enhanced
degradation of cellular BK by MiRP3. B: phosphorimages of total cellular BK
and surface-expressed BK chased for the times specified above the brackets.
For each time point, the samples were loaded–from left to right–from cells
expressing BK with empty vector, MiRP3, and Iip35. C: densities of the bands
in B were quantified for the 16-h period (empty vector, squares; MiRP3,
circles; Iip35, triangles). Arbitrary counts for total cellular expression (filled
symbols) and surface expression (open symbols) are plotted to the left and
right y-axes, respectively. D: half-life of BK expression for 3 experiments is
plotted for total cellular expression (filled bars) and surface expression (open
bars, means 
 SE).
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